Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Inhibition Of HIV-1 Expression By PSF

  • Read more about Inhibition Of HIV-1 Expression By PSF
US Application 60/484,156
Filed on 2003-06-30

Methods for Analysis of Bio markers Concentrated with Biomarker Attractants

  • Read more about Methods for Analysis of Bio markers Concentrated with Biomarker Attractants
US Application 60/509,782
Filed on 2003-10-08

Use Of Cripto-1 As A Biomarker For Neurodegenerative Disease and Method of Inhibiting Progression Thereof

  • Read more about Use Of Cripto-1 As A Biomarker For Neurodegenerative Disease and Method of Inhibiting Progression Thereof
US Application 60/508,750
Filed on 2003-10-03

Equilibrium Thermodynamics-Based Ligand Binding Assays For Macromolecules

  • Read more about Equilibrium Thermodynamics-Based Ligand Binding Assays For Macromolecules
US Application 60/179,559
Filed on 2000-02-01

Host Cells Deficient for Mismatch Repair and Their Use in Methods for Inducing Homologous Recombination Using Single-Stranded Nucleic Acids

  • Read more about Host Cells Deficient for Mismatch Repair and Their Use in Methods for Inducing Homologous Recombination Using Single-Stranded Nucleic Acids
US Application 60/469,494
Filed on 2003-05-09

Methods For Identifying, Diagnosing, And Predicting Survival of Lymphomas

  • Read more about Methods For Identifying, Diagnosing, And Predicting Survival of Lymphomas
US Application 60/500,377
Filed on 2003-09-03

IMMJNOGENIC PEPTIDES OF XAGE-1

  • Read more about IMMJNOGENIC PEPTIDES OF XAGE-1
US Application 60/529,025
Filed on 2003-12-12

Immunogenic Peptides And Peptide Derivatives For The Treatment of Prostate And Breast Cancer Treatment

  • Read more about Immunogenic Peptides And Peptide Derivatives For The Treatment of Prostate And Breast Cancer Treatment
US Application 60/476,467
Filed on 2003-06-05

Method for Ex-Vivo Selection and Expansion of Stimulus-Responding Primary Cells Using Selective Reversible Immortalization

  • Read more about Method for Ex-Vivo Selection and Expansion of Stimulus-Responding Primary Cells Using Selective Reversible Immortalization
US Application 60/528,244
Filed on 2003-12-09

Protection Against Vertical Transmission Of Pathogenic Infections

  • Read more about Protection Against Vertical Transmission Of Pathogenic Infections
US Application 60/472,983
Filed on 2003-05-22

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 173
  • Page 174
  • Page 175
  • Page 176
  • Page 177
  • Page 178
  • Page 179
  • Page 180
  • Page 181
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health